ArticleGynecology and pelvic medicine2026
Pathological features, clinical monitoring, and perinatal outcomes of placental thickening: a report of two cases.
Article in Gynecology and pelvic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Placental thickening is a common clinical abnormality, the definition and clinical guideline for it are not clear. We herein reported two cases of isolated placental thickening (placental thickness >50 mm), with all physical examination findings and laboratory results within normal ranges. Both of the two patients were monitored closely and aggressively treated and led to favorable clinical outcomes. Case Description: One is a 35-year-old gravida 2 para 1 pregnant woman who was first indicated placental thickening at 24 weeks of gestation. She experienced vaginal bleeding with abdominal pain at 38+5 weeks of pregnancy and underwent emergency cesarean sections. The other one is a 32-year-old gravida 2 para 1 pregnant woman who was first indicated placental thickening at 31+1 weeks of gestation. She was found to have persistently low amniotic fluid since 36+6 weeks of pregnancy and an elective cesarean section was performed at 38 weeks. Conclusions: Placental thickening are easily observed clinically, it may be associated with various high-risk pregnancy conditions and adverse perinatal outcomes. However, there's no clear guidelines and only limited insights and data. Accordingly, these cases emphasize the critical clinical implications of placental thickening and proposes that close clinical surveillance is indispensable for improving maternal and fetal prognosis in patients with thickened placentas, with particular relevance to pregnant and postpartum women presenting exclusively with isolated placental thickening and no concurrent obstetric comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.